Activist investor Elliott Investment Management has bought more than a $1 billion stake in BioMarin Pharmaceutical, according to an exclusive report from Reuters published Tuesday, citing two unnamed sources familiar with the matter.
Tag Archive for: activist investor
Contract drug maker Catalent Inc. said on Tuesday it had added four new directors to its board and will conduct a strategic review after reaching a settlement with activist investor Elliott Investment Management.
Amid leadership changes and anti-trust scrutiny, Illumina has lowered its 2023 guidance. The company now expects a 1% increase in revenue, down from its previous 7% to 10% growth forecast.
Illumina Inc. CEO Francis deSouza survived a challenge to his board seat from activist investor Carl Icahn last week by securing more than twice the shareholder votes than the number his challenger received, the company said in a filing on Tuesday.